Home
About Us
- Team
- Careers
Product & Technology
Investors
News & Events
- Press
Contact

Archives Investors-partners

IT Translation Investment

Créazur

Centered Stack Full-Width

Sidebar Slides

Centered Gallery

1
2

Text

Therapixel is one of the leading French software companies specialising in artificial intelligence applied to medical imaging.

LATEST BLOG NEWS

MammoScreen® Breast AI Adopted by Mayo Clinic for Radiology Use June 4, 2025
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network April 4, 2025
Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms October 19, 2022

RECOMMENDED POSTS

MammoScreen® Breast AI Adopted by Mayo Clinic for Radiology Use
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network
Therapixel announces launch of prospective study on the utility of Artificial Intelligence (AI) as part of second reading breast cancer screening mammograms
Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D

© 2023 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences